Tag: investing in Tilt
TILT Holdings Provides Preliminary Fourth Quarter Results, Operational Highlights and 2021 Outlook
TILT Holdings Subsidiary Jupiter Research Receives ISO 13485:2016 Medical Device Certification
TILT Holdings Upgraded to OTCQX® Best Market
TILT Holdings Completes Sale of Blackbird
TILT Holdings Provides Preliminary Third Quarter Results; Announces Senior Leadership Changes to Advance Corporate Strategy
TILT Holdings Announces Financial Results for the Three and Six-Months ended June 30, 2020
Jupiter Research Introduces “Dose-CTI” Metered Dosage Delivery
